NLS Pharmaceutics’ $4 Million Private Placement and Conversion of Existing Short-Term Notes

Federica Tiefenthaler Europe Legal Chronicle
Tagged:

Wenger Vieli advised NLS Pharmaceutics on the deal.NLS Pharmaceutics Ltd., a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here